Is molnupiravir a self-paid drug?

Molnupiravir capsules (Molnupiravir) is a drug used to treat COVID-19. It has some unique characteristics and mechanisms of action. Monoravir capsules are indicated for the treatment of adult patients with confirmed COVID-19 infection, particularly in the early stages of infection. The standard treatment plan is to take 800 mg orally twice a day for 5 consecutive days. The goal of this treatment program is to intervene early, reduce the risk of hospitalization and death, and alleviate symptoms.

Monolavir capsules are already on the market in China, but are not yet included in medical insurance. Please consult your local hospital pharmacy for specific prices. The cheaper ones abroad are Indian generic drugs, which cost around three to four hundred yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.

Clinical trials and research on monogravir capsules have yielded some encouraging results. Preliminary findings suggest that in the setting of early infection, monogravir capsules can significantly reduce the risk of hospitalization and death while mitigating symptoms. However, the safety and effectiveness of medications are still being continuously evaluated and studied.

A number of side effects have been observed in clinical trials and studies of monogravir capsules, including nausea, vomiting, diarrhea, headache, fatigue, abnormal liver function, heart-related problems, and allergic reactions. However, most side effects are short-term and usually mild. Patients should pay close attention to any discomfort while using monogravir capsules and report it to their doctor promptly.

In summary, monogravir capsules represent a new approach to treating COVID-19, with the potential to intervene in early infection, reduce the risk of hospitalization and death, and alleviate symptoms while providing more treatment options. Patients should always follow their doctor's advice before use and pay close attention to the latest developments in relevant research to obtain the best medical care.